When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JAZZ - Jazz Pharma's JZP-258 successful in late-stage study
Jazz Pharmaceuticals plc
A Phase 3 clinical trial evaluating Jazz Pharmaceuticals' (NASDAQ:JAZZ) JZP-258 for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult patients with narcolepsy met the primary endpoint.
More news on: Jazz Pharmaceuticals plc, Healthcare stocks news,